Keating Capital’s President Timothy Keating was interviewed by OneMedRadio where he describes the liquidity premium that gives public companies 3x valuation over private company peers and the dramatic decline in IPOs and increase in size that is debilitating economic growth.
Zack’s Investment Research’s Senior Biotech Analyst, Jason Napodano, was interviewed by OneMedRadio where he discussed International Stem Cell Corp [OTC:ISCO].
OneMedPlace (OMP) announced the creation of OneMedRadio to anchor an expansion of coverage on small public companies in the healthcare and life sciences sector.
Roka Bioscience revealed that it has completed a Series C round of equity financing, raising $20M.
According to a report released by the Institute of Medicine (IOM) Friday, the U.S. Food and Drug Administration needs to develop a new regulatory framework to replace the 35-year-old 510(k) clearance process for medical devices.
With this issue of the newly formatted Sentinel we are introducing OneMedRadio a product designed to bring our readers interviews with the CEOs and investors […]
Paul Keckley noted that things may get worse before they get better in the healthcare and lifescience industry in the United States.
GSV Capital Founder & CEO Michael Moe interviewed by OneMedRadio. GSV raised $50 million in an IPO in May 2011 to invest in emerging technology companies.
Swiss drug maker Novartis said results from a phase three study remarkably improved lung function in a similar way to a rival drug.
Copyright © 2025 | WordPress Theme by MH Themes